The question that prompted this study is the extent to which results from clinical trials can be translated into everyday practice (external validity). First and foremost are questions about tolerability and the efficacy of an antiretroviral combination treatment with Viramune and other antiretroviral partners. In particular, adverse events will be recorded depending on gender and the therapeutic effect will be monitored via the course of viral load and improvement of the immune system, based on the CD4 cell count.
Time Perspective: retro- and prospective
Study Type
OBSERVATIONAL
Enrollment
265
Number of Patients With Virologic Response (VR) After 36 Months
VR is defined as HIV viral load of \< 50 copies/mL before month 36 and without subsequent rebound or change of ARV therapy. A rebound is defined by two consecutive measurements of VL ≥ 50 copies/ml, at least two weeks apart. A change of ARV therapy is defined as a permanent discontinuation of Viramune®. A change in the background therapy due to toxicity or intolerance is not considered failure for the analysis. Therefore, a patient remains a treatment responder in this case if all other criteria are fulfilled. A rebound is defined by two consecutive measurements of VL ≥ 50 copies/ml, at least two weeks apart, after two consecutive measurements of VL\< 50 copies/ml.
Time frame: 36 months
Changes in the Viral Load After 36 Months From Baseline
The change in the log10 viral load from baseline after 36 months was calculated by subtracting the baseline value from the value after 36 months. Therefore, a negative change represents a decrease in viral load.
Time frame: Baseline and 36 months
Changes in the CD4+ Cell Count After 36 Months From Baseline
The change in the Cluster of differentiation 4 (CD4+) cell count from baseline after 36 months was calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase in CD4+ cell count.
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Total Cholesterol) After 36 Months From Baseline
The changes in the laboratory data (Total Cholesterol) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (HDL Cholesterol) After 36 Months From Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Boehringer Ingelheim Investigational Site 23
Aachen, Germany
Boehringer Ingelheim Investigational Site 10
Berlin, Germany
Boehringer Ingelheim Investigational Site 11
Berlin, Germany
Boehringer Ingelheim Investigational Site 14
Berlin, Germany
Boehringer Ingelheim Investigational Site 19
Berlin, Germany
Boehringer Ingelheim Investigational Site 26
Berlin, Germany
Boehringer Ingelheim Investigational Site 28
Berlin, Germany
Boehringer Ingelheim Investigational Site 33
Berlin, Germany
Boehringer Ingelheim Investigational Site 4
Berlin, Germany
Boehringer Ingelheim Investigational Site 5
Berlin, Germany
...and 24 more locations
The changes in the laboratory data ( High density protein (HDL) Cholesterol) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (LDL Cholesterol) After 36 Months From Baseline
The changes in the laboratory data (Low density protein (LDL) Cholesterol) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Triglycerides) After 36 Months From Baseline
The changes in the laboratory data (Triglycerides) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Blood Glucose) After 36 Months From Baseline
The changes in the laboratory data (Blood Glucose) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data ( ALT) After 36 Months From Baseline
The changes in the laboratory data (Alanine transaminase (ALT)) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (AST) After 36 Months From Baseline
The changes in the laboratory data (Aspartate transminase (AST)) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Gamma-GT) After 36 Months From Baseline
The changes in the laboratory data (Gamma glutamyl transferase (Gamma GT)) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Creatinine) After 36 Months From Baseline
The changes in the laboratory data (Creatinine) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months
Changes in the Laboratory Data (Haemoglobin) After 36 Months From Baseline
The changes in the laboratory data (Haemoglobin) from baseline after 36 months were calculated by subtracting the baseline value from the value after 36 months. Therefore, a positive change represents an increase, a negative change represents a decrease in the data. .
Time frame: Baseline and 36 months